Saltar al contenido
Merck
Todas las fotos(1)

Documentos

14-555-M

Sigma-Aldrich

Alk Protein, active, 10 µg

Active, N-terminal His6-tagged, recombinant human ALK, residues 1058-end, for use in Kinase Assays.

Sinónimos:

Anaplastic lymphoma kinase

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Código UNSPSC:
12352202
eCl@ss:
32160405
NACRES:
NA.32

origen biológico

human

Nivel de calidad

recombinante

expressed in baculovirus infected Sf21 cells

mol peso

Mw 63.8 kDa

fabricante / nombre comercial

Upstate®

técnicas

activity assay: suitable (kinase)

Nº de acceso NCBI

Nº de acceso UniProt

Descripción general

Research area: CELL SIGNALING

Product Source: expressed by baculovirus in Sf21 cells

The anaplastic lymphoma kinase (ALK) is a member of the insulin receptor superfamily of receptor tyrosine kinases. The ALK gene is located on human chromosome 2p23 and shares a high similarity with the leukocyte tyrosine kinase (Ltk). ALK is composed of three domains: an extracellular domain responsible for ligand binding, a transmembrane domain that spans the cell membrane, and a cytoplasmic domain housing the tyrosine kinase activity. The cytoplasmic tyrosine kinase domain of ALK plays a significant role in disease pathologies associated with the gene. Within the structure, there are two short conserved β-strands (β7-β8) housing majority of the catalytic residues. Full-length ALK is specifically expressed in the developing central and peripheral nervous systems during embryogenesis and is associated with the balance of cell proliferation and differentiation.

Aplicación

Research Category

Inflammation & Immunology

Acciones bioquímicas o fisiológicas

Protein Target: ALK

Target Sub-Family: TK Anaplastic lymphoma kinase (ALK) plays a crucial role in the development of neurons. Binding of ligand to its extracellular domain triggers the activation of the tyrosine kinase that in turn activates the mitogen-activated protein kinase (MAPK) pathway. ALK fusion proteins induce the activation of diverse pathways including Phospholipase C gamma (PLC-γ) and Ras/Extracellular Signal-Regulated Kinase 1/2 (Ras/ERK1/2), which contribute to cell proliferation, while the Janus Kinase/signal transducer and activator of transcription (JAK/STAT) pathway and Phosphoinositide 3-kinase/Protein Kinase B (PI3K/Akt) pathways facilitate cell survival. Notably, ALK has been found to be overexpressed in various human tumors and cell lines such as lymphomas, neuroblastoma, and non-small-cell lung cancer.

Calidad

routinely evaluated by phosphorylation of IGF-1Rtide

Forma física

Ni2+/NTA-agarose

Almacenamiento y estabilidad

6 months at -70°C from date of shipment

Otras notas

For Specific Activity data, refer to the Certificate of Analysis for individual lots of this enzyme.

Información legal

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Cláusula de descargo de responsabilidad

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.
Passoni, Lorena and Gambacorti-Passerini, Carlo
Leukemia & Lymphoma, 44, 1675-1681 (2003)
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Hallberg B and Palmer RH
Nature Reviews. Cancer, 13(10), 685-700 (2013)
Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition
Roskoski R Jr
Pharmacological Research, 68(1), 68-94 (2013)
Anaplastic lymphoma kinase proteins in growth control and cancer.
Pulford, K, et al.
Journal of Cellular Physiology, 199, 330-358 (2004)
Mechanism for the activation of the anaplastic lymphoma kinase receptor
Reshetnyak AV, et al.
Nature, 600(7887), 153-157 (2021)

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico